Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
24 hour urine potassium output measurement |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
Potassium iodide 65 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning med 2,5 % glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers opløsning med lactat + 5 % glucose + 0,15 % kaliumhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Cerebrospinal fluid potassium measurement (procedure) |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
Dialysis fluid potassium measurement (procedure) |
Component |
False |
Potassium |
Inferred relationship |
Some |
2 |
Potassium iodide 65 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliummiddel til topikal anvendelse |
Is a |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumhydrogenkarbonat 1,39 g + citronsyre 1,14 g opløselig tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
kaliumphosphat injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumphosphat 2 mmol/ml injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumphosphat 2 mmol/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumhydrogenphosphat injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumhydrogenphosphat 1 mmol/ml injektionsvæske, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium 6,5 mmol brusetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium + glucose infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium + glucose/saltvand infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Potassium |
Inferred relationship |
Some |
1 |
Ringers opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium iodide 65 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium iodide 65 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium brusetabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing chlorphenamine and codeine and phenylephrine and potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringer-laktat, opløsning med 2,5 % glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers opløsning med lactat + 5 % glucose + 0,15 % kaliumhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kombinationspræparat med natriumlactat infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Ringers infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing precisely monobasic potassium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing precisely potassium perchlorate 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumiodid 5 g/5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumnitrat 8 % pasta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumjodid 130 mg + teofyllin 80 mg vandfri eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 8 mg + kaliumiodid 150 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium bicarbonate and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium nitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium phosphate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium bicarbonate and potassium bitartrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium bitartrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium iodide and theophylline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing potassium iodide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumnitrat 5 % pasta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 7,5 % syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 500 milligram/1 each conventional release effervescent oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 600 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 %/natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 13,5 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 27 mmol + natriumchlorid 0,9 % infusionsvæske, opløsning i pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mmol/natriumklorid 0,9 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 40 mmol/natriumchlorid 0,9 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
stærk kaliumchlorid 15 % injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
stærk kaliumchlorid 15 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kalium i saltvand til infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 %/natriumchloridd 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 % injektionsvæske, opløsning, ampul a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 % injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium chloride I.V |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
fysiologisk saltvand + kaliumchlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 % + natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv/pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 10 mækv tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 600 mg kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium chloride 1.875 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 20 mækv granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 8 mækv tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 15 mækv/pakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
kaliumchlorid 15 mækv granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Potassium chloride 750 mg10 meq tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|
Product containing precisely potassium chloride 1.5 gram/1 sachet powder for conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Potassium |
Inferred relationship |
Some |
|